Cargando…

Dual mTOR inhibitor MLN0128 suppresses Merkel cell carcinoma (MCC) xenograft tumor growth

Merkel cell carcinoma (MCC) is an aggressive neuroendocrine skin cancer. Pathologic activation of PI3K/mTOR pathway and elevated expression of c-Myc are frequently detected in MCC. Yet, there is no targeted therapy presently available for this lethal disease. Recently, MLN0128, a second-generation d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kannan, Aarthi, Lin, Zhenyu, Shao, Qiang, Zhao, Stephanie, Fang, Bin, Moreno, Mauricio A., Vural, Emre, Stack, Brendan C., Suen, James Y., Kannan, Krishnaswamy, Gao, Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872734/ https://www.ncbi.nlm.nih.gov/pubmed/26536665 http://dx.doi.org/10.18632/oncotarget.5878

Ejemplares similares

Targeting mTOR with MLN0128 Overcomes Rapamycin and Chemoresistant Primary Effusion Lymphoma
por: Caro-Vegas, Carolina, et al.
Publicado: (2019)

MLN0128, a novel mTOR kinase inhibitor, disrupts survival signaling and triggers apoptosis in AML and AML stem/ progenitor cells
por: Zeng, Zhihong, et al.
Publicado: (2016)

Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma
por: Sengupta, Deepanwita, et al.
Publicado: (2015)

A Proteomic Study of Human Merkel Cell Carcinoma
por: Shao, Qiang, et al.
Publicado: (2013)

Selective Inhibition of Aurora Kinase A by AK-01/LY3295668 Attenuates MCC Tumor Growth by Inducing MCC Cell Cycle Arrest and Apoptosis
por: Das, Bhaba K., et al.
Publicado: (2021)

Living with Merkel Cell Carcinoma (MCC): Development of a Conceptual Model of MCC Based on Patient Experiences
por: Kaufman, Howard L., et al.
Publicado: (2018)

Detection of Merkel Cell Polyomavirus (MCPyV) DNA and Transcripts in Merkel Cell Carcinoma (MCC)
por: Passerini, Sara, et al.
Publicado: (2023)

Inhibition of PI3K by copanlisib exerts potent antitumor effects on Merkel cell carcinoma cell lines and mouse xenografts
por: Fang, Bin, et al.
Publicado: (2020)

Metastatic Merkel cell carcinoma (MCC) of pancreas and breast: a unique case
por: Vernadakis, Spiridon, et al.
Publicado: (2013)

Identification and Characterization of Two Novel Oncogenic mTOR Mutations
por: Murugan, Avaniyapuram Kannan, et al.
Publicado: (2019)

Evaluation of Merkel Cell Polyomavirus DNA in Tissue Samples from Italian Patients with Diagnosis of MCC
por: Prezioso, Carla, et al.
Publicado: (2021)

Metachronous Testicular Metastases from Merkel Cell Carcinoma (MCC): A Case Report and Literature Review
por: Laffi, Alice, et al.
Publicado: (2022)

Prolonging hormone sensitivity in prostate cancer xenografts through dual inhibition of AR and mTOR
por: Schayowitz, A, et al.
Publicado: (2010)

Partial Gastric Resection for Symptomatic Anemia following Diagnosis of Merkel Cell Carcinoma (MCC) of the Skin with Gastric Metastasis
por: Eagle, Zachary, et al.
Publicado: (2022)

Bespoke circulating tumor DNA as a biomarker for treatment response in a refractory Merkel cell carcinoma patient
por: Yeakel, John, et al.
Publicado: (2021)

Synergistic targeting of the PI3K/mTOR and MAPK/ERK pathways in Merkel cell carcinoma
por: Temblador, Arturo, et al.
Publicado: (2022)

Response of Merkel Cell Polyomavirus-Positive Merkel Cell Carcinoma Xenografts to a Survivin Inhibitor
por: Dresang, Lindsay R., et al.
Publicado: (2013)

MLN8054 and Alisertib (MLN8237): Discovery of Selective Oral Aurora A Inhibitors
por: Sells, Todd B., et al.
Publicado: (2015)

Single-cell dissection of Merkel cell carcinoma heterogeneity unveils transcriptomic plasticity and therapeutic vulnerabilities
por: Das, Bhaba K., et al.
Publicado: (2023)

A Multi-Parametric Imaging Investigation of the Response of C6 Glioma Xenografts to MLN0518 (Tandutinib) Treatment
por: Boult, Jessica K. R., et al.
Publicado: (2013)

Phase II Prospective Randomized Trial of Weight Loss Prior to Radical Prostatectomy (PCAN-17-0128)
por: Henning, Susanne M, et al.
Publicado: (2017)

Absence of somatic mutations of the mTOR gene in differentiated thyroid cancer
por: Murugan, Avaniyapuram Kannan, et al.
Publicado: (2015)

Correction: A Multi-Parametric Imaging Investigation of the Response of C6 Glioma Xenografts to MLN0518 (Tandutinib) Treatment
por: Boult, Jessica K. R., et al.
Publicado: (2013)

EHMTI-0128. Headache as an initial symptom with the patients treated at the intensive care unit of the Clinic of Neurology 1997 – 2013
por: Vukasinovic, N, et al.
Publicado: (2014)

Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity
por: La Manna, Federico, et al.
Publicado: (2020)

MCC Regulator of WNT Signaling Pathway (MCC) Is a Podocyte Essential Gene
por: Song, Hui, et al.
Publicado: (2021)

OA01.28. Management of post - axial polydactyly by ksharsutra - A minimally invasive Ayurvedic para surgical procedure
por: Dwivedi, Amarprakash
Publicado: (2012)

PA01.28. Pre-storage seed treatments for the maintenance of vigour & viability of aswagandha (Withania somnifera (l.) Dunal)
por: De, Bijay Kumar, et al.
Publicado: (2012)

Corrigendum: Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity
por: La Manna, Federico, et al.
Publicado: (2021)

Biological evaluation of RBx-0128, a potent and selective dipeptidyl peptidase-IV inhibitor in type 2 diabetes genetic model
por: Davis, Joseph A., et al.
Publicado: (2012)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

APC15 mediates CDC20 auto-ubiquitylation by APC/C(MCC) and MCC disassembly
por: Uzunova, Kristina, et al.
Publicado: (2012)

Chronic modulation of AMP-Kinase, Akt and mTOR pathways by ionizing radiation in human lung cancer xenografts
por: Storozhuk, Yaryna, et al.
Publicado: (2012)

Evaluation of the dual mTOR/PI3K inhibitors Gedatolisib (PF-05212384) and PF-04691502 against ovarian cancer xenograft models
por: Langdon, Simon P., et al.
Publicado: (2019)

A Novel In Vitro Culture Model System to Study Merkel Cell Polyomavirus–Associated MCC Using Three-Dimensional Organotypic Raft Equivalents of Human Skin
por: Loke, Amanda S. W., et al.
Publicado: (2021)

Single-Molecule RNA Sequencing Reveals IFNγ-Induced Differential Expression of Immune Escape Genes in Merkel Cell Polyomavirus–Positive MCC Cell Lines
por: Sauerer, Tatjana, et al.
Publicado: (2021)

Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)

MLN-8237: A dual inhibitor of aurora A and B in soft tissue sarcomas
por: Nair, Jayasree S., et al.
Publicado: (2016)

Utilizing 5-aminolevulinic acid and pulsed dye laser for photodynamic therapy of oral leukoplakia – pilot study
por: Shafirstein, Gal, et al.
Publicado: (2010)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_iu4j3rbbd63mrqmov4vv33ofrl